Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Receivables - Other: 2019-2024

Historic Receivables - Other for Legend Biotech (LEGN) over the last 6 years, with Dec 2024 value amounting to $780,000.

  • Legend Biotech's Receivables - Other fell 38.71% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 38.71%. This contributed to the annual value of $780,000 for FY2024, which is 1.27% down from last year.
  • Per Legend Biotech's latest filing, its Receivables - Other stood at $780,000 for FY2024, which was down 1.27% from $790,000 recorded in FY2023.
  • In the past 5 years, Legend Biotech's Receivables - Other registered a high of $50.0 million during FY2021, and its lowest value of $619,000 during FY2020.
  • Over the past 3 years, Legend Biotech's median Receivables - Other value was $790,000 (recorded in 2023), while the average stood at $839,333.
  • In the last 5 years, Legend Biotech's Receivables - Other soared by 7,977.54% in 2021 and then crashed by 98.10% in 2022.
  • Over the past 5 years, Legend Biotech's Receivables - Other (Yearly) stood at $619,000 in 2020, then soared by 7,977.54% to $50.0 million in 2021, then crashed by 98.10% to $948,000 in 2022, then dropped by 16.67% to $790,000 in 2023, then fell by 1.27% to $780,000 in 2024.